New England Section of the American Urological Association

NEAUA Home NEAUA Home Past & Future Meetings Past & Future Meetings

Back to 2024 Abstracts


Emerging Data Regarding Predictors of Patient’s Response to Spermatic Cord Block for Idiopathic Chronic Orchialgia
Daniela Orozco Rendon, BS1, Kathryn McGonagle, BA1, Martin S. Gross, MD2.
1Geisel SOM at Dartmouth, Hanover, NH, USA, 2Dartmouth Health, Hanover, NH, USA

BACKGROUND Approximately 25% to 50% of Chronic Orchialgia is not known to have a specific etiology and is referred to as Idiopathic Chronic Orchialgia (ICO). The evaluation and treatment of this diagnosis can be challenging for physicians given that pathophysiology is not entirely understood. Management algorithms suggest progression to spermatic cord block if conservative management fails. We aimed to better understand the predictive factors of patients who present with ICO and have a response to spermatic cord block (SCB).
METHODS We conducted a retrospective chart review of all male patients presenting to our men’s health urologic clinic with scrotal pain between January 2016-June 2022. 350 patients were reviewed and 88 were determined to qualify as having true ICO without otherwise identifiable cause for their pain. Patients were stratified by having successful or unsuccessful SCB response. They were matched 2 to 1 by age. Chi-Square Test and T-test were run for statistical analysis and a p<0.05 was considered statistically significant. RESULTS A total of 26 patients who had a SCB were responsive to it and 26 were not, after matching for age. Mean duration of pain in those who responded to SCB was about 7 months longer than those who did not respond (p=0.060). Neither the Likert Pain Score nor the Chronic Orchialgia Index Score showed a significant difference between those who responded to SCB and those who did not. In those who responded to SCB, 60% described their pain as constant compared to 37% of those who did not respond to SCB (p=0.025). Only 14% of patients who did not respond to SCB responded to neuromodulating medications while 55% of patients who responded to SCB also responded to these medications. Table 1 summarizes other potential predictive factors for those who respond to SCB for management of their ICO, most not showing a significant difference between cohorts.
CONCLUSION These findings suggest that when evaluating patients for a SCB for the successful management of their ICO, it is important to understand the characteristics of their pain as well as the previous treatment methods that proved effective.
Table 1: Predictive Factors and Response to Spermatic Cord Block

Responded to SCBN=26(%)No Response to SCBN=26(%)X2p-value
PainCharacteristicsIntermittent10(38.5)12(46.2)0.320.5745
Constant15(57.7)7(26.9)5.040.0247
Radiates12(46.2)16(61.5)1.240.2658
Dull10(38.5)6(23.1)1.440.2294
Achy7(26.9)4(15.4)1.040.3084
Sharp/Stabbing12(46.2)6(23.1)3.060.0803
Othe Symptoms7(26.9)7(26.9)0.001.000
Medical HistoryHistory of Vasectomy7(26.9)8(30.7)0.090.7595
Other UrologicalCondition14(53.8)13(50.0)0.080.7814
Social HistoryAlcohol Use at First Encounter12*(60.0)13**(59.1)0.0040.9522
Tobacco Use at First Encounter5(19.2)5***(20.0)0.0050.9449
Physical ExamTenderness to Palpation16(61.5)20(76.9)1.440.2294
Response to Previous ManagementConservative Measurements3+(21.4)2++(16.7)0.090.7587
Oral Neuromodulating Pain Medications6+++(54.5)2+(14.3)4.590.0322

*N20, **N=22, ***N=25, + N=14, ++N=12, +++N=11
Back to 2024 Abstracts